Children hospitalized with RSV showed higher risk for ICU admission, IMV, and supplemental oxygen than children hospitalized with COVID-19 or influenza.

Cuts to Medicaid prompted by the One Big Beautiful Bill Act could lead to thousands of excess deaths each year.

Janus kinase (JAK) inhibitors are associated with decreased mortality and fewer serious adverse events among adults hospitalized with COVID-19.

IV induction followed by subcutaneous maintenance therapy with guselkumab is efficacious for adults with moderately to severely active Crohn disease.

The controversial preservative thimerosal will be stripped from all influenza vaccines distributed in the United States.

Pemivibart was well tolerated and prophylactic against COVID-19 infection among adult patients with significant immunocompromising conditions.

HealthDay News — The U.S. Department of Health and Human Services, U.S. Department of Agriculture, and U.S. Food and Drug Administration are gathering data to create a uniform definition of ...

Presumptive measles immunity rates were low among patients with HIV at a large US clinic, indicating targeted solutions to increase vaccine uptake are need for this at-risk population.

Step-down therapy with laLGPs may be an appropriate alternative to standard care antibiotics for patients with severe gram-positive bacterial infections.

The FDA has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

Two types of tuna sold in 7 states are being recalled due to listeria concerns, according to the US Food and Drug Administration.

The efficacy and safety of efinaconazole 10% solution is acceptable among older adults with onychomycosis and comparable to the general population.